Valuation: Kenvue Inc.

Market Cap 37.92B 33.28B 30.99B 28.5B 53.43B 3,623B 54.35B 368B 144B 1,797B 142B 139B 6,207B P/E 2026 *
20.7x
P/E 2027 * 18.5x
Enterprise Value 45.33B 39.78B 37.04B 34.07B 63.87B 4,330B 64.96B 439B 172B 2,148B 170B 166B 7,420B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.79x
Free-Float
98.9%
Yield 2026 *
4.3%
Yield 2027 * 4.39%
1 day-0.53%
1 week+2.61%
Current month+2.72%
1 month+2.94%
3 months+13.93%
6 months+14.13%
Current year+13.80%
1 week 18.77
Extreme 18.77
20.05
1 month 18.58
Extreme 18.58
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.35
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
6/29/26
Starboard Value LP
OtherCompany 1,413 0.0001%
6/29/26 Free

Director

1,413 0.0001%
6/10/26 Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.48%+2.61%-11.46%-17.10% 37.92B
-2.59%-2.86%-7.50%-7.32% 347B
-0.70%+7.73%-0.31%+5.42% 143B
-0.35%+0.49%+6.01%+20.74% 74.2B
+4.70%-1.71%-13.69%-17.30% 49.75B
-1.77%+0.89%-8.79%-53.68% 30.66B
+0.38%+2.72%-26.96%-31.36% 20.07B
-0.82%-0.68%+13.71%+6.78% 19.62B
+2.98%+5.85%+1.47%+26.58% 18.35B
+0.90%+0.72%-11.08%+3.91% 11.43B
Average +0.20%+1.97%-5.86%-6.33% 75.18B
Weighted average by Cap. -1.13%+2.05%-5.26%-4.44%

Financials

2026 *2027 *
Net sales 15.63B 13.71B 12.77B 11.75B 22.02B 1,493B 22.39B 151B 59.3B 740B 58.66B 57.39B 2,558B 16.02B 14.06B 13.09B 12.04B 22.57B 1,531B 22.96B 155B 60.8B 759B 60.15B 58.85B 2,623B
Net income 1.84B 1.62B 1.51B 1.39B 2.6B 176B 2.64B 17.87B 6.99B 87.32B 6.92B 6.77B 302B 2.06B 1.81B 1.69B 1.55B 2.91B 197B 2.96B 20.02B 7.84B 97.83B 7.75B 7.58B 338B
Net Debt 7.41B 6.5B 6.05B 5.57B 10.44B 708B 10.61B 71.81B 28.11B 351B 27.8B 27.2B 1,212B 6.81B 5.98B 5.57B 5.12B 9.6B 651B 9.76B 66.03B 25.85B 323B 25.57B 25.02B 1,115B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-29 US$19.65 -0.53% 1,641,809
26-07-28 US$19.75 +1.39% 19,625,025
26-07-27 US$19.48 +1.04% 20,910,019
26-07-24 US$19.28 +2.01% 21,434,276
26-07-23 US$18.90 -1.20% 14,410,892
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.75USD
Average target price
19.83USD
Spread / Average Target
+0.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock